Protective efficacy of an oral vaccine to reduce carriage of Borrelia burgdorferi (strain N40) in mouse and tick reservoirs

Vaccine

Volumn 24, Issue 11, 2006, Pages 1949-1957

  Scheckelhoff, Mark R ^a   Telford, Sam R ^b   Hu, Linden T ^a  

^a TUFTS MEDICAL CENTER   (United States)

^b TUFTS UNIVERSITY   (United States)

Author keywords

Lyme disease; OspA; Vaccinia virus

Indexed keywords

ANTIBODY; BACTERIAL VACCINE; OUTER SURFACE PROTEIN A; VIRUS VECTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY TITER; ARTICLE; BACTERIAL STRAIN; BACTERIAL TRANSMISSION; BORRELIA BURGDORFERI; BORRELIA INFECTION; CONTROLLED STUDY; DISEASE TRANSMISSION; DRUG EFFICACY; FEMALE; HOST; LYME DISEASE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTECTION; PROTEIN EXPRESSION; RESERVOIR; SINGLE DRUG DOSE; TICK; VACCINATION;

ADMINISTRATION, ORAL; ANIMALS; ANTIBODIES, BACTERIAL; ANTIGENS, SURFACE; BACTERIAL OUTER MEMBRANE PROTEINS; BACTERIAL VACCINES; BORRELIA BURGDORFERI; DISEASE RESERVOIRS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; LIPOPROTEINS; LYME DISEASE; LYME DISEASE VACCINES; MICE; MICE, INBRED C3H; MICE, INBRED DBA; RABBITS; TICKS; VACCINES, SYNTHETIC; VACCINIA VIRUS;

EID: 32544450111     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2005.10.044     Document Type: Article

References (52)

1. A.C. Steere, J. Coburn, and L. Glickstein The emergence of Lyme disease J Clin Invest 113 8 2004 1093 1101
2. L.H. Sigal, J.M. Zahradnik, P. Lavin, S.J. Patella, G. Bryant, and R. Haselby A vaccine consisting of recombinant Borrelia burgdorferi outer-surface protein A to prevent Lyme disease. Recombinant outer-surface protein A Lyme disease vaccine study consortium N Engl J Med 339 4 1998 216 222
3. U. Pal, A.M. de Silva, R.R. Montgomery, D. Fish, J. Anguita, and J.F. Anderson Attachment of Borrelia burgdorferi within Ixodes scapularis mediated by outer surface protein A J Clin Invest 106 4 2000 561 569
4. U. Pal, X. Li, T. Wang, R.R. Montgomery, N. Ramamoorthi, and A.M. Desilva TROSPA, an Ixodes scapularis receptor for Borrelia burgdorferi Cell 119 4 2004 457 468
5. X.F. Yang, U. Pal, S.M. Alani, E. Fikrig, and M.V. Norgard Essential role for OspA/B in the life cycle of the Lyme disease spirochete J Exp Med 199 5 2004 641 648
6. P.S. Hefty, S.E. Jolliff, M.J. Caimano, S.K. Wikel, and D.R. Akins Changes in temporal and spatial patterns of outer surface lipoprotein expression generate population heterogeneity and antigenic diversity in the Lyme disease spirochete, Borrelia burgdorferi Infect Immun 70 7 2002 3468 3478
7. T.G. Schwan, and J. Piesman Temporal changes in outer surface proteins A and C of the lyme disease-associated spirochete, Borrelia burgdorferi, during the chain of infection in ticks and mice J Clin Microbiol 38 1 2000 382 388
8. X. Yang, M.S. Goldberg, T.G. Popova, G.B. Schoeler, S.K. Wikel, and K.E. Hagman Interdependence of environmental factors influencing reciprocal patterns of gene expression in virulent Borrelia burgdorferi Mol Microbiol 37 6 2000 1470 1479
9. A.M. de Silva, D. Fish, T.R. Burkot, Y. Zhang, and E. Fikrig OspA antibodies inhibit the acquisition of Borrelia burgdorferi by Ixodes ticks Infect Immun 65 8 1997 3146 3150
10. A.M. de Silva, S.R. Telford 3rd, L.R. Brunet, S.W. Barthold, and FikrigF E. Borrelia burgdorferi OspA is an arthropod-specific transmission-blocking Lyme disease vaccine J Exp Med 183 1 1996 271 275
11. M.D. Kramer, R. Wallich, and M.M. Simon The outer surface protein A (OspA) of Borrelia burgdorferi: a vaccine candidate and bioactive mediator Infection 24 2 1996 190 194
12. U.E. Schaible, R. Wallich, M.D. Kramer, G. Nerz, T. Stehle, and C. Museteanu Protection against Borrelia burgdorferi infection in SCID mice is conferred by presensitized spleen cells and partially by B but not T cells alone Int Immunol 6 5 1994 671 681
13. M.M. Simon, U.E. Schaible, M.D. Kramer, C. Eckerskorn, C. Museteanu, and H.K. Muller-Hermelink Recombinant outer surface protein a from Borrelia burgdorferi induces antibodies protective against spirochetal infection in mice J Infect Dis 164 1 1991 123 132
14. U. Pal, R.R. Montgomery, D. Lusitani, P. Voet, V. Weynants, and S.E. Malawista Inhibition of Borrelia burgdorferi-tick interactions in vivo by outer surface protein A antibody J Immunol 166 12 2001 7398 7403
15. S.R. Telford, F.S. Kantor 3rd, Y. Lobet, S.W. Barthold, A. Spielman, and R.A. Flavell Efficacy of human Lyme disease vaccine formulations in a mouse model J Infect Dis 171 5 1995 1368 1370
16. J.M. Pound, J.A. Miller, J.E. George, and C.A. Lemeilleur The '4-poster' passive topical treatment device to apply acaricide for controlling ticks (Acari: Ixodidae) feeding on white-tailed deer J Med Entomol 37 4 2000 588 594
17. R. Wallich, M.D. Kramer, and M.M. Simon The recombinant outer surface protein A (lipOspA) of Borrelia burgdorferi: a Lyme disease vaccine Infection 24 5 1996 396 397
18. M. Dunne, B.K. al-Ramadi, S.W. Barthold, R.A. Flavell, and E. Fikrig Oral vaccination with an attenuated Salmonella typhimurium strain expressing Borrelia burgdorferi OspA prevents murine Lyme borreliosis Infect Immun 63 4 1995 1611 1614
19. J.I. Tsao, J.T. Wootton, J. Bunikis, M.G. Luna, D. Fish, and A.G. Barbour An ecological approach to preventing human infection: Vaccinating wild mouse reservoirs intervenes in the Lyme disease cycle Proc Natl Acad Sci USA 101 52 2004 18159 18164
20. E.J. Im, and T. Hanke MVA as a vector for vaccines against HIV-1 Expert Rev Vaccines 3 4 Suppl. 2004 S89 S97
21. B. Brochier, M.F. Aubert, P.P. Pastoret, E. Masson, J. Schon, and M. Lombard Field use of a vaccinia-rabies recombinant vaccine for the control of sylvatic rabies in Europe and North America Rev Sci Tech 15 3 1996 947 970
22. E. Prieur, S.C. Gilbert, J. Schneider, A.C. Moore, E.G. Sheu, and N. Goonetilleke A Plasmodium falciparum candidate vaccine based on a six-antigen polyprotein encoded by recombinant poxviruses Proc Natl Acad Sci USA 101 1 2004 290 295
23. P.P. Pastoret, D. Boulanger, and B. Brochier Field trials of a recombinant rabies vaccine Parasitology 110 Suppl. 1995 S37 S42
24. D.E. Roscoe, W.C. Holste, F.E. Sorhage, C. Campbell, M. Niezgoda, and R. Buchannan Efficacy of an oral vaccinia-rabies glycoprotein recombinant vaccine in controlling epidemic raccoon rabies in New Jersey J Wildl Dis 34 4 1998 752 763
25. M.G. Fearneyhough, P.J. Wilson, K.A. Clark, D.R. Smith, D.H. Johnston, and B.N. Hicks Results of an oral rabies vaccination program for coyotes J Am Vet Med Assoc 212 4 1998 498 502
26. F. Cliquet, and M. Aubert Elimination of terrestrial rabies in Western European countries Dev Biol (Basel) 2004 119185 119204
27. E. Masson, V. Bruyere-Masson, P. Vuillaume, S. Lemoyne, and M. Aubert Rabies oral vaccination of foxes during the summer with the VRG vaccine bait Vet Res 30 6 1999 595 605
28. B. Brochier, J. Blancou, I. Thomas, B. Languet, M. Artois, and M.P. Kieny Use of recombinant vaccinia-rabies glycoprotein virus for oral vaccination of wildlife against rabies: innocuity to several non-target bait consuming species J Wildl Dis 25 4 1989 540 547
29. C.A. Hanlon, M. Niezgoda, A.N. Hamir, C. Schumacher, H. Koprowski, and C.E. Rupprecht First North American field release of a vaccinia-rabies glycoprotein recombinant virus J Wildl Dis 34 2 1998 228 239
30. P.P. Pastoret, and B. Brochier The development and use of a vaccinia-rabies recombinant oral vaccine for the control of wildlife rabies; a link between Jenner and Pasteur Epidemiol Infect 116 3 1996 235 240
31. P.P. Pastoret, B. Brochier, and D. Boulanger Target and non-target effects of a recombinant vaccinia-rabies virus developed for fox vaccination against rabies Dev Biol Stand 1995 84183 84193
32. C.E. Rupprecht, L. Blass, K. Smith, L.A. Orciari, M. Niezgoda, and S.G. Whitfield Human infection due to recombinant vaccinia-rabies glycoprotein virus N Engl J Med 345 8 2001 582 586
33. M.W. McGuill, S.M. Kreindel, A. DeMaria Jr., A.H. Robbins, S. Rowell, and C.A. Hanlon Human contact with bait containing vaccine for control of rabies in wildlife J Am Vet Med Assoc 213 10 1998 1413 1417
34. R. Blasco, and B. Moss Role of cell-associated enveloped vaccinia virus in cell-to-cell spread J Virol 66 7 1992 4170 4179
35. B. Moss Expression of proteins in mammalian cells using vaccinia viral vectors R.B. Fred M. Ausubel R.E. Kingston D.D. Moore J.G. Seidman J.A. Smith K. Struhl Current protocols in molecular biology 1991 John Wiley & Sons Inc. New York 16.15.1 16.17.16
36. X.G. Wang, B. Lin, J.M. Kidder, S. Telford, and L.T. Hu Effects of environmental changes on expression of the oligopeptide permease (opp) genes of Borrelia burgdorferi J Bacteriol 184 22 2002 6198 6206
37. Zdrodovskii PF, Golinevich HM. The Rickettsial Diseases. New York: Pergamon Press; 1960.
38. E. Fikrig, S.R. Telford, S.W. Barthold, F.S. Kantor, and R.A. Flavell Elimination of Borrelia burgdorferi from vector ticks feeding on OspA-immunized mice PNAS 89 12 1992 5418 5421
39. C.L. Gipson, N.L. Davis, R.E. Johnston, and A.M. de Silva Evaluation of Venezuelan equine encephalitis (VEE) replicon-based outer surface protein A (OspA) vaccines in a tick challenge mouse model of Lyme disease Vaccine 21 25-26 2003 3875 3884
40. R. Blasco, and B. Moss Selection of recombinant vaccinia viruses on the basis of plaque formation Gene 158 2 1995 157 162
41. L.T. Hu, S.D. Pratt, G. Perides, L. Katz, R.A. Rogers, and M.S. Klempner Isolation, cloning, and expression of a 70-kilodalton plasminogen binding protein of Borrelia burgdorferi Infect Immun 65 12 1997 4989 4995
42. J.G. Donahue, J. Piesman, and A. Spielman Reservoir competence of white-footed mice for Lyme disease spirochetes Am J Trop Med Hyg 36 1 1987 92 96
43. T.B. Morrison, Y. Ma, J.H. Weis, and J.J. Weis Rapid and sensitive quantification of Borrelia burgdorferi-infected mouse tissues by continuous fluorescent monitoring of PCR J Clin Microbiol 37 4 1999 987 992
44. A.G. Barbour, G.O. Maupin, G.J. Teltow, C.J. Carter, and J. Piesman Identification of an uncultivable Borrelia species in the hard tick Amblyomma americanum: possible agent of a Lyme disease-like illness J Infect Dis 173 2 1996 403 409
45. M.M. Simon, L. Gern, P. Hauser, W. Zhong, P.J. Nielsen, and M.D. Kramer Protective immunization with plasmid DNA containing the outer surface lipoprotein A gene of Borrelia burgdorferi is independent of an eukaryotic promoter Eur J Immunol 26 12 1996 2831 2840
46. C. Van Hoecke, M. Comberbach, D. De Grave, P. Desmons, D. Fu, and P. Hauser Evaluation of the safety, reactogenicity and immunogenicity of three recombinant outer surface protein (OspA) lyme vaccines in healthy adults Vaccine 14 17-18 1996 1620 1626
47. R. Xu, A.J. Johnson, D. Liggitt, and M.J. Bevan Cellular and humoral immunity against vaccinia virus infection of mice J Immunol 172 10 2004 6265 6271
48. C. Terman Population dynamics J. King Biology of peromyscus (Rodentia) 1968 American Society of Mammologists Special Publications 593
49. B.M. Brochier, B. Languet, J. Blancou, M.P. Kieny, J.P. Lecocq, and F. Costy Use of recombinant vaccinia-rabies virus for oral vaccination of fox cubs (Vulpes vulpes L.) against rabies Vet Microbiol 18 2 1988 103 108
50. M.J. Gomes-Solecki, D.R. Brisson, and R.J. Dattwyler Oral vaccine that breaks the transmission cycle of the Lyme disease spirochete can be delivered via bait Vaccine 2005
51. C.J. Luke, R.C. Huebner, V. Kasmiersky, and A.G. Barbour Oral delivery of purified lipoprotein OspA protects mice from systemic infection with Borrelia burgdorferi Vaccine 15 6-7 1997 739 746
52. M.C. Dolan, G.O. Maupin, B.S. Schneider, C. Denatale, N. Hamon, and C. Cole Control of immature Ixodes scapularis (Acari: Ixodidae) on rodent reservoirs of Borrelia burgdorferi in a residential community of southeastern Connecticut J Med Entomol 41 6 2004 1043 1054